CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Celgene Corp  (CELG)
Other Ticker:  
 


Celgene's Gross Profit Margin by quarter

Trends, Rankings, Statistics



CELG Gross Profit Margin (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Revenue Change 16.14 % 15.36 % 13.76 % 15.91 % 18.41 %
Seq. Revenue Change 2.73 % 9.32 % -0.3 % 3.73 % 2.05 %
Revenue In Millions $4,520.00 $4,400.00 $4,025.00 $4,037.00 $3,892.00
Gross Profit Margin 96.31 % 96.57 % 96.52 % 95.79 % 95.97 %
Gross Profit Margin Total Ranking # 921 # 895 # 724 # 607 # 298
Gross Profit In Millions $4,353.00 $4,249.00 $3,885.00 $3,867.00 $3,735.00
Y / Y Gross Profit Change 16.55 % 15.21 % 14.16 % 15.09 % 17.86 %
Seq. Gross Profit Change 2.45 % 9.37 % 0.47 % 3.53 % 1.27 %

New: More CELG's historic Gross Margin results >>

Commenting Third Quarter 2019 Gross Profit Margin
Celgene has managed to improve its Revenue sequentially to $4,520 millions by 2.73 % faster than Gross Profit increase of 2.45 % to $4,353 millions, this led to contraction in Gross Profit Margin to 96.31 %, but the Celgene III. Quarter Gross Profit Margin remained above company average rate of 92.42%.

Observing third quarter 2019 results within Major Pharmaceutical Preparations industry 130 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated compare to previous quarter from 895 to 921.
Learn about Gross Margin
CELG's Gross Profit Margin third quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 131
Healthcare Sector # 202
Overall # 892

Gross Profit Margin Statistics
High Average Low
96.7 % 92.42 % 82.09 %
(Jun 30 2018)   (Sep. 30, 2005)


CELG Gross Income Trends • More of CELG's Profitabilty Ratios • CELG Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
CELG's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CELG's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CELG's Competitors
Gross Profit Margin Profit Margin for Celgene's Suppliers
Gross Profit Margin Profit Margin for CELG's Customers

You may also want to know
CELG's Annual Growth Rates CELG's Profitability Ratios CELG's Asset Turnover Ratio CELG's Dividend Growth
CELG's Roe CELG's Valuation Ratios CELG's Financial Strength Ratios CELG's Gross Profit Growth
CELG's Roa CELG's Inventory Turnover Ratio CELG's Growth Rates CELG's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2019, within Major Pharmaceutical Preparations Industry Gross Profit MarginSep 30 2019 MRQ Gross ProfitSep 30 2019 MRQ Revenue
Enanta Pharmaceuticals Inc  236.20 %$ 121.199 $ 51.313 
Cnbx Pharmaceuticals Inc   212.73 %$ 0.004 $ 0.002 
Regen Biopharma Inc   198.92 %$ 0.055 $ 0.028 
Arrowhead Pharmaceuticals Inc   180.05 %$ 77.951 $ 43.293 
Arbutus Biopharma Corp  100.00 %$ 3.061 $ 3.061 
Acura Pharmaceuticals inc  100.00 %$ 1.324 $ 1.324 
Ayala Pharmaceuticals Inc   100.00 %$ 0.001 $ 0.001 
Albireo Pharma inc   100.00 %$ 1.385 $ 1.385 
Alpine Immune Sciences Inc   100.00 %$ 0.289 $ 0.289 
Altimmune inc   100.00 %$ 0.944 $ 0.944 
Aptinyx Inc   100.00 %$ 0.936 $ 0.936 
Arcturus Therapeutics Holdings Inc   100.00 %$ 3.318 $ 3.318 
Arena Pharmaceuticals Inc   100.00 %$ 1.350 $ 1.350 
Arqule Inc  100.00 %$ 0.208 $ 0.208 
Arvinas Inc   100.00 %$ 30.050 $ 30.050 
Assembly Biosciences Inc   100.00 %$ 4.231 $ 4.231 
Aveo Pharmaceuticals Inc   100.00 %$ 25.717 $ 25.717 
Bridgebio Pharma Inc   100.00 %$ 26.741 $ 26.741 
Bicycle Therapeutics Plc  100.00 %$ 0.614 $ 0.614 
Bellicum Pharmaceuticals Inc   100.00 %$ 0.426 $ 0.426 
Blueprint Medicines Corporation  100.00 %$ 9.139 $ 9.139 
Biospecifics Technologies Corp  100.00 %$ 9.442 $ 9.442 
Capricor Therapeutics inc   100.00 %$ 0.142 $ 0.142 
Cara Therapeutics inc   100.00 %$ 5.785 $ 5.785 
Chemocentryx Inc.  100.00 %$ 21.162 $ 21.162 
Checkpoint Therapeutics inc   100.00 %$ 0.280 $ 0.280 
Clearside Biomedical Inc   100.00 %$ 0.141 $ 0.141 
Chimerix inc   100.00 %$ 1.958 $ 1.958 
Concert Pharmaceuticals Inc   100.00 %$ 0.010 $ 0.010 
Cocrystal Pharma Inc   100.00 %$ 0.492 $ 0.492 




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com